Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 239 of 1,261

  1. US 11446353

    Compositions and methods for the treatment of fungal infections

    Arizona Board of Regents on Behalf of Northern Arizona University · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  2. US 11446332

    Combinatorial cancer immunotherapy

    Senti Biosciences, Inc. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  3. US 11446342

    Composite probiotics and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  4. US 11446331

    Wound healing and tissue engineering

    United States Government as represented by the Department of Veterans Affairs · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  5. US 11445997

    Ultrasound imaging of biomarker sensitive hydrogels

    SENTIOMED, INC. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  6. US 11450420

    Secure smart dosing system with automated delivery, measurement, and management for pills

    Vivera Pharmaceuticals Inc. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  7. US 11446310

    Stable formulations for parenteral injection of small molecule drugs

    XERIS PHARMACEUTICALS, INC. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  8. US 11446357

    Method for treating disease using FOXP3+CD4+ T cells

    Kyverna Therapeutics, Inc. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  9. US 11446279

    Aromatic 2-nitrosulfonyl fluoride antibiotics and methods of use thereof

    The Regents of the University of California · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  10. US 11446302

    Compounds with anti-tumor activity against cancer cells bearing EGFR or HER2 exon 20 mutations

    The Board of Regents of the University of Texas System · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  11. US 11447500

    Thienopyridine derivatives and pharmaceutical composition comprising same

    Wellmarker Bio Co., LTD. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  12. US 11446253

    Ionic liquids for internal delivery

    The Regents of the University of California · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  13. US 11446271

    Methods and compositions for increasing the potency of antifungal agents

    PACIFIC NORTHWEST RESEARCH INSTITUTE · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  14. US 11440939

    Anticancer peptides

    IDP DISCOVERY PHARMA, S.L. · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted

  15. US 11440883

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted

  16. US 11440885

    Substituted 1-arylalkyl-4-acylaminopiperidine compounds and methods of producing and using the same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted

  17. US 11439725

    Bioresorbable embolization microspheres

    Regents of the University of Minnesota · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted

  18. US 11440943

    Therapeutic interferon alpha 1 proteins

    Orionis Biosciences, Inc · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted

  19. US 11439709

    Phospholipid ether analogs as cancer-targeting drug vehicles

    CELLECTAR BIOSCIENCES, INC. · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted

  20. US 11441184

    Method for generating retinal pigment epithelium (RPE) cells from induced pluripotent stem cells (IPSCs)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted

  21. US 11439695

    Kidney injury treatment

    The Regents of the University of California · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted

  22. US 11440951

    Therapeutic antibodies to Marburg virus

    The Government of the United States, as represented by the Secretary of the Army · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted

  23. US 11440961

    Anti TRBC1 antigen binding domains

    AUTOLUS LIMITED · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted

  24. US 11439708

    Nanotube trans-membrane channels mimicking biological porins

    The Regents of the University of California · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.